SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on November 3, 2010. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant is incorporated in Delaware with principal executive offices in Bethesda, Maryland.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a regulatory event rather than a financial statement.
Material Changes and Events
Under Item 7.01 (Regulation FD Disclosure), the Company announced that on November 4, 2010, Dr. Robert A. Lodder (President) and Ms. Leisa Dennehy (Commercial and Corporate Development Advisor) will deliver a presentation to prospective investors at the Windhover's Therapeutic Area Partnerships Conference in Boston, MA.
- The presentation is attached as Exhibit 99.1 and is available on the Company's website.
- The content of the presentation is incorporated by reference into this filing.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future performance, or a discussion of risks and contingencies beyond the disclosure of the upcoming investor presentation. No unusual items were reported in this document.
Key Facts for Investor Verification
- Verify the content of the investor presentation attached as Exhibit 99.1 for any forward-looking statements or strategic updates.
- Confirm the date and location of the Windhover's Therapeutic Area Partnerships Conference (November 4, 2010, Boston, MA).
- Note that this filing does not contain updated financial results; investors should refer to the most recent 10-K or 10-Q for financial data.